Is eR-α36 , a novel variant of estrogen receptor α , involved in EGFR-related carcinogenesis in endometrial cancer?
ER-α36 mediates EGFR-related extracellular signal-regulated kinase activation in endometrial cancer.
These analyses indicate that, for several common cancers, transplant patients experience worse outcomes than the general population. The data also suggest that cancers in transplant recipients are more aggressive biologically at the time of diagnosis.